JP2013014622A5 - - Google Patents

Download PDF

Info

Publication number
JP2013014622A5
JP2013014622A5 JP2012230565A JP2012230565A JP2013014622A5 JP 2013014622 A5 JP2013014622 A5 JP 2013014622A5 JP 2012230565 A JP2012230565 A JP 2012230565A JP 2012230565 A JP2012230565 A JP 2012230565A JP 2013014622 A5 JP2013014622 A5 JP 2013014622A5
Authority
JP
Japan
Prior art keywords
solvate
pharmaceutically acceptable
acceptable salt
compound
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012230565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013014622A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013014622A publication Critical patent/JP2013014622A/ja
Publication of JP2013014622A5 publication Critical patent/JP2013014622A5/ja
Pending legal-status Critical Current

Links

JP2012230565A 2007-03-15 2012-10-18 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 Pending JP2013014622A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91817107P 2007-03-15 2007-03-15
US60/918,171 2007-03-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009553612A Division JP5147866B2 (ja) 2007-03-15 2008-03-12 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013259117A Division JP2014051529A (ja) 2007-03-15 2013-12-16 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Publications (2)

Publication Number Publication Date
JP2013014622A JP2013014622A (ja) 2013-01-24
JP2013014622A5 true JP2013014622A5 (enExample) 2014-02-06

Family

ID=39525788

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009553612A Expired - Fee Related JP5147866B2 (ja) 2007-03-15 2008-03-12 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体
JP2012230565A Pending JP2013014622A (ja) 2007-03-15 2012-10-18 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体
JP2013259117A Pending JP2014051529A (ja) 2007-03-15 2013-12-16 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009553612A Expired - Fee Related JP5147866B2 (ja) 2007-03-15 2008-03-12 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013259117A Pending JP2014051529A (ja) 2007-03-15 2013-12-16 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Country Status (18)

Country Link
US (1) US8232274B2 (enExample)
EP (2) EP2586778A3 (enExample)
JP (3) JP5147866B2 (enExample)
KR (1) KR20100049500A (enExample)
CN (1) CN101730692A (enExample)
AR (1) AR065721A1 (enExample)
AU (1) AU2008227100B2 (enExample)
BR (1) BRPI0809238A2 (enExample)
CA (1) CA2680583A1 (enExample)
CL (1) CL2008000725A1 (enExample)
CO (1) CO6220966A2 (enExample)
EC (1) ECSP099634A (enExample)
IL (1) IL200906A0 (enExample)
MX (1) MX2009009948A (enExample)
PE (1) PE20081882A1 (enExample)
RU (1) RU2009137946A (enExample)
TW (1) TW200902516A (enExample)
WO (1) WO2008115381A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101668529A (zh) * 2007-03-15 2010-03-10 先灵公司 用作葡聚糖合成酶抑制剂的哌嗪取代的哒嗪酮衍生物
JP5550352B2 (ja) 2007-03-15 2014-07-16 ノバルティス アーゲー 有機化合物およびその使用
AU2008302570B2 (en) * 2007-09-20 2012-05-31 Irm Llc Compounds and compositions as modulators of GPR119 activity
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン, インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
EP2627635A1 (en) * 2010-10-11 2013-08-21 Axikin Pharmaceuticals, Inc. Salts of arylsulfonamide ccr3 antagonists
FI20115234A0 (fi) 2011-03-08 2011-03-08 Biotie Therapies Corp Uusia pyridatsinoni- ja pyridoniyhdisteitä
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
JO3115B1 (ar) * 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
UA111861C2 (uk) 2011-11-15 2016-06-24 Такеда Фармасьютікал Компані Лімітед Ароматична гетероциклічна сполука дигідрокси
CN104379563B (zh) * 2012-04-10 2018-12-21 加利福尼亚大学董事会 用于治疗癌症的组合物和方法
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
CN103664795B (zh) * 2012-09-06 2017-10-03 华东理工大学 哒嗪酮类化合物及其用途
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014053973A2 (en) 2012-10-05 2014-04-10 Koninklijke Philips N.V. Medical imaging system and method for providing an enhanced x-ray image
GB201222711D0 (en) * 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
EP3039019B1 (en) * 2013-08-26 2020-04-22 Purdue Pharma L.P. Azaspiro[4.5]decane derivatives and use thereof
CN106459042B (zh) 2014-04-02 2019-06-28 英特穆恩公司 抗纤维化吡啶酮类
WO2015161348A1 (en) * 2014-04-24 2015-10-29 Hexima Limited Agents and methods of treatment
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
CU20190096A7 (es) 2017-03-15 2020-10-20 Lunella Biotech Inc Compuestos derivados de 3-metil-3-hidroxi-4-[(n,n-dimetil)amino]-9-[2-(benciloxi)bencil]-1-oxa-9-azaspiro[5,5]undecano substituidos como inhibidores de la función mitocondrial y composiciones farmacéuticas que los contienen
US20210101874A1 (en) 2017-04-03 2021-04-08 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
CA3075727A1 (en) 2017-09-18 2019-03-21 Goldfinch Bio, Inc. Pyridazinones and methods of use thereof
CN109912476A (zh) * 2019-03-27 2019-06-21 南通宝凯化工有限公司 一种异丙氨基磺酰氯的生产工艺
CN112469713B (zh) * 2019-06-21 2023-09-01 江苏豪森药业集团有限公司 芳基磷氧化物类衍生物抑制剂、其制备方法和应用
US12509444B2 (en) * 2019-12-06 2025-12-30 Plexxikon Inc. Compounds and methods for CD73 modulation and indications therefor
BR112022021963A2 (pt) 2020-04-30 2022-12-13 Gilead Sciences Inc Inibidores macrocíclicos de peptidilarginina desiminases
WO2023204124A1 (ja) * 2022-04-20 2023-10-26 日本曹達株式会社 ピリダジノン化合物並びに農園芸用殺菌剤、殺線虫剤、および医療用・動物用抗真菌剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS565734B2 (enExample) * 1973-02-28 1981-02-06
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
ES8601972A1 (es) 1985-02-28 1985-11-16 Abello Quimicos Farma Prod Sa Procedimiento de obtencion de 1,2-diazin-3 (2h)-onas con interes farmaceutico
JPH04235975A (ja) * 1991-01-21 1992-08-25 Nissan Chem Ind Ltd ピリダジノン誘導体および害虫防除剤
GB2256587A (en) 1991-06-11 1992-12-16 American Cyanamid Co Acetazolamide in sustained release form
HU227237B1 (en) * 2001-09-27 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them
TW200306822A (en) * 2002-01-31 2003-12-01 Daiichi Seiyaku Co Imidazo[1, 2-a]pyridine derivative
DE10216144A1 (de) * 2002-04-12 2003-11-06 Bayer Ag Substituierte 2-Phenyl-3(2H)-Pyridazinone
US20050209278A1 (en) * 2002-04-25 2005-09-22 Mcdonald Joseph J Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
CN1905873A (zh) * 2003-11-19 2007-01-31 阵列生物制药公司 Mek的杂环抑制剂及其使用方法
JP5213229B2 (ja) * 2004-04-23 2013-06-19 エグゼリクシス, インコーポレイテッド キナーゼ調節因子および使用方法
GB0524991D0 (en) * 2005-12-08 2006-01-18 Ge Healthcare Ltd Novel imaging agents for fibrosis
WO2007130383A2 (en) * 2006-04-28 2007-11-15 Northwestern University Compositions and treatments using pyridazine compounds and secretases
CN101668529A (zh) * 2007-03-15 2010-03-10 先灵公司 用作葡聚糖合成酶抑制剂的哌嗪取代的哒嗪酮衍生物

Similar Documents

Publication Publication Date Title
JP2013014622A5 (enExample)
JP2014507446A5 (enExample)
JP2012107057A5 (enExample)
JP2012126725A5 (enExample)
JP2017509667A5 (enExample)
JP2016518337A5 (enExample)
JP2014221779A5 (enExample)
JP2011105738A5 (enExample)
EP2833721A4 (en) NICKEL OXIDE RELEASING PHARMACEUTICAL COMPOSITIONS
JP2015525757A5 (enExample)
JP2013525444A5 (enExample)
JP2012143233A5 (enExample)
JP2015501783A5 (enExample)
ZA201501977B (en) Orally administered medical composition
JP2011006431A5 (enExample)
JP2013509429A5 (enExample)
JP2013520167A5 (enExample)
JP2013532687A5 (enExample)
JP2014530840A5 (enExample)
JP2016535100A5 (enExample)
JP2019516735A5 (enExample)
TWI559929B (en) Pharmaceutical composition for use in the treatment of a neurodegenerative disease
JP2016500312A5 (enExample)
PL3003285T3 (pl) Stała farmaceutyczna postać dawkowania do uwalniania co najmniej dwóch substancji czynnych w jamie ustnej
BR112014020992A2 (pt) Composto,uso de composto na fabricação de um medicamento e composição farmacêutica